氨磺必利治疗精神分裂症40例临床疗效初探

[1] I mprovement of acute exacerbations of schizophrenia with amisulpride:a compari-son with haloperidol.PROD-ASLP Study Group. Mller HJ,Boyer P,Fleurot O,et al. Psychopharmacology . 1997

[2] Amisulpride versus flupentixol in schizophrenia with predominantly positive symptomatology-a double-blind controlled study comparing a selective D2 -like antagonist to a mixed D1 - D2 -like antagonist. Wetzel H,Grunder G,Hillert A,et al. Psychopharmacology . 1998

[3] From pharmacological profiles to clinical out-comes. Kerwin R. International Clinical Psychopharmacology . 2000

[4] Amisulpride vs. risperidone in the treatment of acute exacerbations of schizophrenia. Peuskens,J,Bech,P,M?ller,HJ,Bale,R,Fleurot,O,Rein,W. Psychiatry Research . 1999

[5] Psychopharmacological profile of amisulpride.An antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity. Perrault G H,Depoortere D,Morel E,et al. Journal of Pharmacology and Experimental Therapeutics . 1997

[6] Neurochemical characteristics of Amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity. Schoemaker H,Claustre Y,Fage D,et al. Journal of Pharmacology and Experimental Therapeutics . 1997

[7] Amisulpride versus flupentixol in schizophrenia with predominantly positive symptomatology – a double-blind controlled study comparing a selective D2-like antagonist to a mixed D1-/D2-like antagonist[J] . H. Wetzel,G. Gründer,A. Hillert,M. Philipp,W. F. Gattaz,H. Sauer,G. Adler,J. Schr?der,W. Rein,O. Benkert. &nbspPsychopharmacology . 1998 (3)

[8] Improvement of acute exacerbations of schizophrenia with amisulpride: a comparison with haloperidol[J] . H. J. M?ller,P. Boyer,O. Fleurot,W. Rein. &nbspPsychopharmacology . 1997 (4)

[9] Amisulpride:from ani mal pharmacology to therapeutic action. Scatton B,Claustre Y,Cudennec A,et al. Int Clin Psy-chopharmacol . 1997

[1] I mprovement of acute exacerbations of schizophrenia with amisulpride:a compari-son with haloperidol.PROD-ASLP Study Group. Mller HJ,Boyer P,Fleurot O,et al. Psychopharmacology . 1997

[2] Amisulpride versus flupentixol in schizophrenia with predominantly positive symptomatology-a double-blind controlled study comparing a selective D2 -like antagonist to a mixed D1 - D2 -like antagonist. Wetzel H,Grunder G,Hillert A,et al. Psychopharmacology . 1998

[3] From pharmacological profiles to clinical out-comes. Kerwin R. International Clinical Psychopharmacology . 2000

[4] Amisulpride vs. risperidone in the treatment of acute exacerbations of schizophrenia. Peuskens,J,Bech,P,M?ller,HJ,Bale,R,Fleurot,O,Rein,W. Psychiatry Research . 1999

[5] Psychopharmacological profile of amisulpride.An antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity. Perrault G H,Depoortere D,Morel E,et al. Journal of Pharmacology and Experimental Therapeutics . 1997

[6] Neurochemical characteristics of Amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity. Schoemaker H,Claustre Y,Fage D,et al. Journal of Pharmacology and Experimental Therapeutics . 1997

[7] Amisulpride versus flupentixol in schizophrenia with predominantly positive symptomatology – a double-blind controlled study comparing a selective D2-like antagonist to a mixed D1-/D2-like antagonist[J] . H. Wetzel,G. Gründer,A. Hillert,M. Philipp,W. F. Gattaz,H. Sauer,G. Adler,J. Schr?der,W. Rein,O. Benkert. &nbspPsychopharmacology . 1998 (3)

[8] Improvement of acute exacerbations of schizophrenia with amisulpride: a comparison with haloperidol[J] . H. J. M?ller,P. Boyer,O. Fleurot,W. Rein. &nbspPsychopharmacology . 1997 (4)

[9] Amisulpride:from ani mal pharmacology to therapeutic action. Scatton B,Claustre Y,Cudennec A,et al. Int Clin Psy-chopharmacol . 1997